We recently identified two mechanisms that are considered to be key drivers of ChAc pathophysiology due to VPS13A deficiency: decreased phosphoinositide-3-kinase signaling and increased activity of Src family tyrosine kinase Lyn (for review, see [4]). Here, VPS13A is linked to chorea-acanthocytosis.